Month: September 2024

Rescuing Failing Projects: The Power of a Midsize CRO

In the fast-paced clinical research world, projects can sometimes veer off course. When this happens, the flexibility, expertise and speed of a midsize Contract Research Organization (CRO) like Sword Bio can be invaluable. These organizations strike the perfect balance between flexibility, experience, and efficiency, making them ideal partners for rescuing projects failing with another CRO….

Read More...

The Use of dPCR Assays for VCN and Ratio of Full to Empty Capsids and Viral Titer in Lentiviral Gene Therapy Products

Precision and accuracy are paramount in the rapidly evolving field of gene therapy. A biotech company recently developed a gene therapy product using a Lentivirus Vector. To ensure the effectiveness of this product, it was crucial to determine the transfection efficiency and the quantity of viral vectors used for gene therapy delivery. This required the…

Read More...

Harnessing the Power of the MSD System for Cellular Neutralizing Antibody Assays

In the ever-evolving field of immunology, the role of neutralizing antibodies (NAbs) cannot be overstated. These antibodies play a pivotal role in the immune response, neutralizing therapeutics and preventing them from binding to cells. Cell-based NAb assays, a cornerstone of biomedical research, enable scientists to delve into cellular responses to various stimuli. The Meso Scale…

Read More...

Custom Biomarkers: When, where, and how to use them in the growing biotherapeutic industry.

Custom Biomarkers are measurable indicators that provide valuable insights into biological processes, health conditions, and disease states. They serve as diagnostic tools and prognostic markers and are specific for the therapeutic targets. Biomarkers play a pivotal role in new drug development, providing valuable insights for decision-making in therapy development. We can evaluate the significance of…

Read More...

The Rising Importance of Custom Antibody Generation for Biotherapeutics

As biotherapeutics continues to evolve, the development of more specific and targeted treatments has become a primary focus. This shift has led to a decrease in the use of commercial antibodies as therapeutic reagents and an increase in the generation of custom antibodies tailored to specific biotherapeutics. Biotherapeutics, also known as biological therapies, involve using…

Read More...